TOOL DEVELOPMENT FOR MEASURING AVARANA (OCCLUSION OF BODY CHANNELS) AND ASSESSMENT OF THE EFFECT OF SELECTED AYURVEDIC ANTIAVARANA DRUGS, IN METABOLIC SYNDROME
Phase 3
Completed
- Conditions
- Health Condition 1: null- Participants with and without Metabolic syndrome
- Registration Number
- CTRI/2018/05/013837
- Lead Sponsor
- DrPriyaS
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 220
Inclusion Criteria
The subjects with the age group of 30-70years with and without Metabolic syndrome were included in the study. Those who were ready to give consent, for the administration of the draft tool were only included in phase 1.In phase 2, the diagnosed cases of metabolic syndrome with newly developed Avarana tool (AMT-MS) score above 22 were included.
Exclusion Criteria
Patients with other major systemic diseases and the patients who were not co-operating with the study were excluded in both phases
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method